Skip to main content

Table 1 Clinical characteristics

From: Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction

Characteristics

NSTEMI (n = 238)

STEMI (n = 474)

P value

Age (y)

68.00 (60.00, 78.25)

65.00 (56.00, 73.00)

 < 0.001

Male, n (%)

153 (64.3)

327 (69.0)

0.207

History of drinking alcohol, n (%)

67 (28.2)

133 (28.1)

0.979

Diabetes mellitus, n (%)

81 (34.0)

135 (28.5)

0.128

Hypertension, n (%)

144 (60.5)

247 (52.1)

0.034

History of smoking, n (%)

138 (58.0)

270 (57.0)

0.795

Family history of CVD, n (%)

7 (2.9)

13 (2.7)

0.880

Prior cerebral infarction, n (%)

27 (11.3)

72 (15.2)

0.162

Prior MI, n (%)

52 (21.8)

47 (9.9)

 < 0.001

WBC count (109/L)

9.10 (6.99, 11.89)

10.52 (8.42, 13.52)

 < 0.001

Neutrophil count (109/L)

6.68 (4.85, 9.27)

8.28 (6.34, 11.29)

 < 0.001

RBC count (1012/L)

4.50 (3.98, 4.92)

4.62 (4.24, 5.01)

0.007

Hemoglobin (g/L)

136.50 (120.00, 153.00)

142.00 (127.00, 155.00)

0.005

Platelet count (109/L)

218.50 (184.75, 257.25)

225.00 (187.50, 264.00)

0.314

FPG (mmol/L)

6.04 (4.93, 8.37)

6.02 (5.04, 8.82)

0.831

Triglycerides (mmol/L)

1.46 (1.05, 1.94)

1.44 (0.98, 2.17)

0.953

TC (mmol/L)

4.68 (3.83, 5.41)

4.62 (3.93, 5.33)

0.917

HDL-C (mmol/L)

1.14 (0.94, 1.38)

1.14 (0.96, 1.34)

0.884

LDL-C (mmol/L)

2.84 (2.20, 3.38)

2.83 (2.29, 3.39)

0.707

AST (U/L)

49.90 (29.95, 122.48)

137.10 (53.90, 252.08)

 < 0.001

ALT (U/L)

27.55 (18.35, 51.83)

44.15 (27.20, 72.43)

 < 0.001

GGT (U/L)

31.70 (21.00, 58.95)

36.75 (23.48, 59.15)

0.146

ALP (U/L)

89.60 (73.03, 106.43)

87.7 0(73.30, 106.43)

0.663

Cholinesterase (U/L)

7907.50 (6330.00, 9412.50)

8072.50 (6471.50, 9471.00)

0.394

Albumin (g/L)

36.85 (34.28, 40.10)

36.80 (34.10, 39.23)

0.521

T-Bil (µmol/L)

13.70 (9.88, 18.40)

13.50 (9.78, 18.70)

0.931

D-Bil (µmol/L)

4.00 (2.80, 5.00)

4.00 (3.00, 5.30)

0.864

PTA (%)

101.00 (93.00, 111.00)

101.00 (92.00, 109.00)

0.319

PT (s)

11.30 (10.70, 11.73)

11.30 (10.80, 11.90)

0.339

INR

0.97 (0.92, 1.01)

0.97 (0.92, 1.02)

0.318

Fibrinogen (g/L)

3.46 (3.05, 4.15)

3.51 (2.94, 4.21)

0.942

Tn I (ng/mL)

0.79 (0.15, 5.01)

5.47 (0.43, 20.75)

 < 0.001

Myoglobin (ng/mL)

239.50 (109.00, 500.00)

500.00 (173.75, 500.00)

 < 0.001

CK-MB (ng/mL)

6.60 (2.30, 25.58)

24.85 (4.38, 67.90)

 < 0.001

BNP (pg/mL)

175.00 (43.93, 1020.00)

119.50 (22.88, 489.25)

0.005

D-dimer (ng/mL)

204.00 (100.00, 702.00)

170.00 (100.00, 749.25)

0.564

Creatinine (µmol/L)

76.35 (63.38, 105.80)

72.05 (60.30, 89.28)

0.007

BUN (mmol/L)

6.61 (5.17, 8.95)

6.04 (5.09, 7.62)

0.006

Liver-protecting, n (%)

16 (6.7)

61 (12.9)

0.013

In-hospital death, n (%)

72 (30.3)

120 (25.3)

0.162

  1. Continuous variables are expressed as median (25th, 75th percentiles). Categorical variables are shown as numbers (percentages)
  2. ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CK-MB, creatine kinase MB; CVD, cardiovascular disease; D-Bil, direct bilirubin; FPG, fasting plasma glucose; GGT, γ-glutamyl transpeptidase; HDL-C, high-density lipoprotein cholesterol; INR, international normalized ratio; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; NSTEMI, non–ST-segment elevation myocardial infarction; PT, prothrombin time; PTA, prothrombin time activity; RBC, red blood cell; STEMI, ST-segment elevation myocardial infarction; T-Bil, total bilirubin; TC, total cholesterol; Tn I, cardiac troponin I; WBC, white blood cell
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us